A merger of two of Australia’s largest pathology providers is dead in the water after the regulator blocked the move, citing fears it would lessen competition. Shortly after the Australian Competition and Consumer Commission’s announcement on Friday, Australian Clinical Labs said it did not want to go ahead with its acquisition of Healius anyway, due […]

This post was originally published on Michael West.